Subscribe To
Jazz pharmaceuticals begins enrollment for clinical trial to evaluate jzp150 for adults with ptsd
Biopharmaceutical company Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced Thursday that it has enrolled the first patient in its Phase 2 clinical tr...
December 30, 2021, 1:11 pm
Jazz pharmaceuticals begins enrollment for clinical trial to evaluate jzp150 for adults with ptsd
Biopharmaceutical company Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced Thursday that it has enrolled the first patient in its Phase 2 clinical tr...
December 30, 2021, 1:11 pm
Jazz pharmaceuticals begins enrollment for clinical trial to evaluate jzp150 for adults with ptsd
Biopharmaceutical company Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced Thursday that it has enrolled the first patient in its Phase 2 clinical tr...
December 30, 2021, 1:11 pm
Regenxbio: accumulating for the long haul
RGNX announced promising safety and efficacy data from its SCS micro injector trial....
December 26, 2021, 6:48 am
Regenxbio: accumulating for the long haul
RGNX announced promising safety and efficacy data from its SCS micro injector trial....
December 26, 2021, 6:48 am
Regenxbio: accumulating for the long haul
RGNX announced promising safety and efficacy data from its SCS micro injector trial....
December 26, 2021, 6:48 am
Sesen bio to conduct additional trial for potential resubmission of vicineum in bladder cancer
Sesen Bio Inc (NASDAQ: SESN) has outlined its anticipated regulatory path forward for Vicineum for BCG-unresponsive non-muscle invasive bladder can...
December 9, 2021, 1:09 pm
Sesen bio to conduct additional trial for potential resubmission of vicineum in bladder cancer
Sesen Bio Inc (NASDAQ: SESN) has outlined its anticipated regulatory path forward for Vicineum for BCG-unresponsive non-muscle invasive bladder can...
December 9, 2021, 1:09 pm
Sesen bio to conduct additional trial for potential resubmission of vicineum in bladder cancer
Sesen Bio Inc (NASDAQ: SESN) has outlined its anticipated regulatory path forward for Vicineum for BCG-unresponsive non-muscle invasive bladder can...
December 9, 2021, 1:09 pm
cactus, inc. (whd) down 13.2% since last earnings report: can it rebound?
cactus, Inc. (WHD) reported earnings 30 days ago. What's next for the stock?...
December 3, 2021, 1:00 pm
cactus, inc. (whd) down 13.2% since last earnings report: can it rebound?
cactus, Inc. (WHD) reported earnings 30 days ago. What's next for the stock?...
December 3, 2021, 1:00 pm
cactus, inc. (whd) down 13.2% since last earnings report: can it rebound?
cactus, Inc. (WHD) reported earnings 30 days ago. What's next for the stock?...
December 3, 2021, 1:00 pm
Redhill biopharma's talicia for bacterial infections shows efficacy irrespective of patient bmi
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study of Talicia to treat H. pylori infection....
December 2, 2021, 1:22 pm
Redhill biopharma's talicia for bacterial infections shows efficacy irrespective of patient bmi
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study of Talicia to treat H. pylori infection....
December 2, 2021, 1:22 pm
Redhill biopharma's talicia for bacterial infections shows efficacy irrespective of patient bmi
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study of Talicia to treat H. pylori infection....
December 2, 2021, 1:22 pm
Dynamic dividend outlook could make sdog super
In recent weeks, equity income investors were treated to a flurry of encouraging dividend news with more arriving prior to the Thanksgiving holiday in...
November 29, 2021, 1:09 pm
Dynamic dividend outlook could make sdog super
In recent weeks, equity income investors were treated to a flurry of encouraging dividend news with more arriving prior to the Thanksgiving holiday in...
November 29, 2021, 1:09 pm
Dynamic dividend outlook could make sdog super
In recent weeks, equity income investors were treated to a flurry of encouraging dividend news with more arriving prior to the Thanksgiving holiday in...
November 29, 2021, 1:09 pm
Sesen bio: hoping for an easy revalidation of vicineum by 2022
The US FDA published the warning letter on October 27, 2021, just 2 days before CMC Type A meeting with Sesen Bio. The move informed its rejection of ...
November 16, 2021, 9:11 pm
Sesen bio: hoping for an easy revalidation of vicineum by 2022
The US FDA published the warning letter on October 27, 2021, just 2 days before CMC Type A meeting with Sesen Bio. The move informed its rejection of ...
November 16, 2021, 9:11 pm